Votre partenaire de valorisation et transfert
Inserm Transfert (inserm-transfert.fr) scores 73 out of 100 on Brand Analyzer, placing it in the Brand-Ready tier among Healthcare brands, Education brands, Other brands, in the 36th percentile of 19608 Healthcare brands.
Inserm Transfert is the private subsidiary of Inserm, France's national health and medical research institute, created in 2000 under a public service delegation. Based in Paris, it specializes in technology transfer in the life sciences, supporting Inserm research units and researchers in valorizing scientific discoveries. It connects fundamental, technological, clinical and applied research with industrial and institutional partners, aiming to convert research outcomes into economic and societal value.
| Brand Name | Inserm Transfert |
|---|---|
| Domain | inserm-transfert.fr |
| Industry | Healthcare, Education |
| Founded | 2000 |
| Headquarters | Paris |
| Parent Company / Owner | Inserm |
| Main Competitors | CNRS Innovation, Erganeo, SATT Paris-Saclay (76/100), SATT Lutech, Institut Pasteur (77/100), INRAE Transfert (80/100), Fraunhofer-Gesellschaft (37/100) |
Moz Domain Authority 35/100 vs category average 40 / leader 95 - limited third-party links, so AI systems rarely encounter mentions of the brand.
No Wikipedia presence was found - a major gap, since Wikipedia is among the most heavily weighted sources in AI training data.
The homepage meta description reads "Inserm Transfert, fondée en 2000, est la filiale privée de l’Inserm spécialisée dans le transfert de technologies en sciences de la vie" (Meta description: 22 words (ideal length). OG description present and descriptive) - this is the summary AI engines are most likely to quote.
Structured data on the homepage: 1 JSON-LD block(s), Organization schema, Breadcrumb/Website schema, og:title, og:description, og:image, og:type, Twitter cards. Adding FAQ schema would further help AI crawlers parse the brand's identity.
AI-crawler access: robots.txt present, no AI bot restrictions - robots.txt controls whether engines like GPTBot and ClaudeBot can read the site at all.
Content is FR-only, limiting citation in English-language AI answers.
Detected tech stack: Apache, WordPress, Ghost.
Social footprint: verified profiles on X (Twitter), LinkedIn, YouTube, Facebook, Instagram; no detected presence on GitHub - consistent profiles reinforce the brand's identity across the web.
0 Reddit mentions - community discussion signals real-world reputation to AI models.
Live results from asking a general-purpose AI assistant about the brand, checked October 2026.
When asked "What is Inserm Transfert?", Claude could identify the brand as of October 2026. Inserm Transfert is the technology transfer subsidiary of Inserm, France's national institute for health and medical research, responsible for managing intellectual property, licensing, and industry partnerships arising from Inserm's biomedical research. It helps translate academ Best known for Managing technology transfer and licensing of biomedical research discoveries from Inserm, France's main health research institute.
When asked "Best brands similar to Inserm Transfert?", Claude would recommend Inserm Transfert as of October 2026. It's a well known and important player in French biomedical tech transfer, so it would naturally come up in discussions of academic research commercialization or European life sciences innovation ecosystems.
Common questions people ask in Google, ChatGPT, Claude, Gemini, Perplexity, and other AI search engines.
Inserm Transfert's main competitors in Healthcare: SATT Paris-Saclay (76/100), Institut Pasteur (77/100), INRAE Transfert (80/100), Fraunhofer-Gesellschaft (37/100).
Sources: Brand Analyzer scan
Inserm Transfert offers technology transfer and research valorization services, including support for Inserm research units and researchers in developing collaborative projects with industrial and institutional partners across fundamental, technological, clinical and applied life sciences research.
Sources: Inserm Transfert official site
Inserm Transfert is the private subsidiary of Inserm, France's national institute for health and medical research, founded in 2000. It operates under a public service delegation and specializes in the transfer of technologies arising from life sciences research. It is headquartered in Paris.
Sources: Inserm Transfert official site
Inserm Transfert has limited AI-search visibility, scoring 33/100 on Brand Analyzer's AI visibility composite (visibility 21, trust 39, recommendation 48). This estimates how likely AI engines like ChatGPT, Claude, Gemini and Perplexity are to know, trust, and recommend the brand.
Sources: Inserm Transfert official site
Inserm Transfert is headquartered in Paris. Inserm Transfert operates in the Healthcare category.
Sources: Wikidata
Inserm Transfert accompanies Inserm research units and researchers in the valorization and transfer of life sciences technologies. It combines scientific expertise with technology transfer skills to help convert fundamental research into applications with economic and societal value, often through partnerships with industrial and institutional actors.
Sources: Inserm Transfert official site
Inserm Transfert scores 48/100 on Brand Analyzer's AI recommendation signal, indicating it is less likely to be surfaced when AI assistants like ChatGPT suggest Healthcare options. Recommendation depends on crawlability, structured data, and category authority.
Sources: Inserm Transfert official site
Inserm Transfert is known for being the dedicated technology transfer arm of Inserm, linking fundamental, technological, clinical and applied research in the life sciences to industrial and institutional partners for development and commercialization.
Sources: Inserm Transfert official site
Inserm Transfert can improve AI discoverability by strengthening structured data (Organization and FAQ schema), maintaining an accurate Wikipedia/Wikidata entity, earning authoritative citations, and keeping content crawlable for AI bots. Brand Analyzer measures these as visibility, trust, and recommendation signals.
Sources: Inserm Transfert official site
Inserm Transfert's services are used by Inserm researchers and research units, as well as industrial and institutional partners involved in collaborative life sciences research and development projects.
Sources: Inserm Transfert official site
Inserm Transfert scores 33/100 for AI visibility - how well ChatGPT, Claude, Perplexity and Google AI Overviews can discover, identify and cite the brand.
Inserm Transfert has a weak AI-visibility profile at 33/100 - a proxy for how readily ChatGPT, Perplexity and Google's AI Overviews can recognise and cite it. Its strongest area is recommendation likelihood (48/100) and its weakest is visibility (21/100). It benefits from a Wikidata knowledge-graph entry, open access for AI crawlers (GPTBot, ClaudeBot, etc.) and machine-readable schema.org markup. The main gaps holding it back: no clear Wikipedia entity to anchor it in LLM training data, a low Moz Domain Authority of 35/100 and no llms.txt to steer AI to its best pages. In a live check, Claude could already identify Inserm Transfert from memory (October 2026) - a sign these signals are paying off.
The score combines seven dimensions - name quality, digital presence, visual identity, messaging clarity, trust foundation, AI discoverability, and brand authority - into a single objective benchmark.
Ranked closest to Inserm Transfert: Innovatus Imaging (73/100), OPPI (73/100), Instramed (73/100), Interpharma (73/100).
A step up - brands to learn from: Zymo Research (81/100), Zurich Insurance Group (81/100).
Category leader: Booksy (96/100).
Brand Analyzer is built by DataEase AI. Track your brand in ChatGPT, Gemini and Perplexity.